_PRIVATE_LIMITED.webp)
Blancco Diagnostics (India) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 10.00 K
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 10.82%
- Profit Growth 20.02%
- Ebitda 89.40%
- Net Worth 21.25%
- Total Assets 18.02%
About Blancco Diagnostics (India)
Blancco Diagnostics (India) Private Limited (BDIPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 April 2016 (Eight years and nine months 24 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Jaslieen Baghh and George Janssen serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999PN2016PTC164058
-
Company No.
164058
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Apr 2016
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Blancco Diagnostics (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaslieen Baghh
|
Director | 17-Mar-2017 | Current |
George Janssen
|
Director | 26-Nov-2018 | Current |
Financial Performance of Blancco Diagnostics (India).
Blancco Diagnostics (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.82% increase. The company also saw a substantial improvement in profitability, with a 20.02% increase in profit. The company's net worth Soared by an impressive increase of 21.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Blancco Diagnostics (India)?
In 2023, Blancco Diagnostics (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Blancco (Software) India Private LimitedJaslieen Baghh and George Janssen are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Blancco Diagnostics (India)?
Blancco Diagnostics (India) has a workforce of 65 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blancco Diagnostics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blancco Diagnostics (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
